Royal Bank of Canada’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $551K | Sell |
|
|||||
|
2025
Q2 | $248K | Buy |
|
|||||
|
2025
Q1 | $4K | Sell |
|
|||||
|
2024
Q4 | $15K | Sell |
|
|||||
|
2024
Q3 | $14K | Buy |
|
|||||
|
2024
Q2 | $18K | Buy |
|
|||||
|
2024
Q1 | $11K | Sell |
|
|||||
|
2023
Q4 | $107K | Sell |
|
|||||
|
2023
Q3 | $139K | Buy |
|
|||||
|
2023
Q2 | $117K | Buy |
|
|||||
|
2023
Q1 | $182K | Sell |
|
|||||
|
2022
Q4 | $248K | Buy |
|
|||||
|
2022
Q3 | $285K | Sell |
|
|||||
|
2022
Q2 | $287K | Buy |
|
|||||
|
2022
Q1 | $336K | Sell |
|
|||||
|
2021
Q4 | $535K | Buy |
|
|||||
|
2021
Q3 | $408K | Sell |
|
|||||
|
2021
Q2 | $516K | Sell |
|
|||||
|
2021
Q1 | $593K | Sell |
|
|||||
|
2020
Q4 | $851K | Buy |
|
|||||
|
2020
Q3 | $781K | Buy |
|
|||||
|
2020
Q2 | $701K | Buy |
|
|||||
|
2020
Q1 | $585K | Sell |
|
|||||
|
2019
Q4 | $840K | Buy |
|
|||||
|
2019
Q3 | $924K | Buy |
|
|||||
|
2019
Q2 | $590K | Sell |
|
|||||
|
2019
Q1 | $377K | Sell |
|
|||||
|
2018
Q4 | $869K | Buy |
|
|||||
|
2018
Q3 | $477K | Sell |
|
|||||
|
2018
Q2 | $461K | Buy |
|
|||||
|
2018
Q1 | $360K | Buy |
|
|||||
|
2017
Q4 | $227K | Buy |
|
|||||
|
2017
Q3 | $95K | Buy |
|
|||||
|
2017
Q2 | $48K | Buy |
|
|||||
|
2017
Q1 | $29K | Sell |
|
|||||
|
2016
Q4 | $56K | Sell |
|
|||||
|
2016
Q3 | $471K | Buy |
|
|||||
|
2016
Q2 | $10K | Sell |
|
|||||
|
2016
Q1 | $344K | Buy |
|
|||||
|
2015
Q4 | $0 | Sell |
|
|||||
|
2015
Q3 | $21K | Sell |
|
|||||
|
2015
Q2 | $746K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $1K | Buy |
|